Declining mortality from kidney cancer in Europe

Fabio Levi, F. Lucchini, E. Negri, C. La Vecchia

Research output: Contribution to journalArticle

Abstract

Mortality rates from kidney cancer increased throughout Europe up until the late 1980s or early 1990s. Trends in western European countries, the European Union (EU) and selected central and eastern European countries have been updated using official death certification data for kidney cancer abstracted from the World Health Organisation (WHO) database over the period 1980-1999. In EU men, death rates increased from 3.92 per 100 000 (age standardised, world standard) in 1980- 81 to 4.63 in 1994-95, and levelled off at 4.15 thereafter. In women, corresponding values were 1.86 in 1980-81, 2.04 in 1994-95 and 1.80 in 1998-99. Thus, the fall in kidney cancer mortality over the last 5 years was over 10% for both sexes in the EU. The largest falls were in countries with highest mortality in the early 1990s, such as Germany, Denmark and the Netherlands. Kidney cancer rates levelled off, but remained very high, in the Czech Republic, Baltic countries, Hungary, Poland and other central European countries. Thus, in the late 1990s, a greater than three-fold difference in kidney cancer mortality was observed between the highest rates in the Czech Republic, the Baltic Republics and Hungary, and the lowest ones in Romania, Portugal and Greece. Tobacco smoking is the best recognised risk factor for kidney cancer, and the recent trends in men, mainly in western Europe, can be related to a reduced prevalence of smoking among men. Tobacco, however, cannot account for the recent trends registered in women.

Original languageEnglish
Pages (from-to)1130-1135
Number of pages6
JournalAnnals of Oncology
Volume15
Issue number7
DOIs
Publication statusPublished - Jul 2004

Fingerprint

Kidney Neoplasms
Mortality
European Union
Hungary
Czech Republic
Smoking
Romania
Portugal
Greece
Certification
Poland
Denmark
Netherlands
Tobacco
Germany
Databases

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Levi, F., Lucchini, F., Negri, E., & La Vecchia, C. (2004). Declining mortality from kidney cancer in Europe. Annals of Oncology, 15(7), 1130-1135. https://doi.org/10.1093/annonc/mdh270

Declining mortality from kidney cancer in Europe. / Levi, Fabio; Lucchini, F.; Negri, E.; La Vecchia, C.

In: Annals of Oncology, Vol. 15, No. 7, 07.2004, p. 1130-1135.

Research output: Contribution to journalArticle

Levi, F, Lucchini, F, Negri, E & La Vecchia, C 2004, 'Declining mortality from kidney cancer in Europe', Annals of Oncology, vol. 15, no. 7, pp. 1130-1135. https://doi.org/10.1093/annonc/mdh270
Levi F, Lucchini F, Negri E, La Vecchia C. Declining mortality from kidney cancer in Europe. Annals of Oncology. 2004 Jul;15(7):1130-1135. https://doi.org/10.1093/annonc/mdh270
Levi, Fabio ; Lucchini, F. ; Negri, E. ; La Vecchia, C. / Declining mortality from kidney cancer in Europe. In: Annals of Oncology. 2004 ; Vol. 15, No. 7. pp. 1130-1135.
@article{aa2694e8413845b4ae26865947a4c0bf,
title = "Declining mortality from kidney cancer in Europe",
abstract = "Mortality rates from kidney cancer increased throughout Europe up until the late 1980s or early 1990s. Trends in western European countries, the European Union (EU) and selected central and eastern European countries have been updated using official death certification data for kidney cancer abstracted from the World Health Organisation (WHO) database over the period 1980-1999. In EU men, death rates increased from 3.92 per 100 000 (age standardised, world standard) in 1980- 81 to 4.63 in 1994-95, and levelled off at 4.15 thereafter. In women, corresponding values were 1.86 in 1980-81, 2.04 in 1994-95 and 1.80 in 1998-99. Thus, the fall in kidney cancer mortality over the last 5 years was over 10{\%} for both sexes in the EU. The largest falls were in countries with highest mortality in the early 1990s, such as Germany, Denmark and the Netherlands. Kidney cancer rates levelled off, but remained very high, in the Czech Republic, Baltic countries, Hungary, Poland and other central European countries. Thus, in the late 1990s, a greater than three-fold difference in kidney cancer mortality was observed between the highest rates in the Czech Republic, the Baltic Republics and Hungary, and the lowest ones in Romania, Portugal and Greece. Tobacco smoking is the best recognised risk factor for kidney cancer, and the recent trends in men, mainly in western Europe, can be related to a reduced prevalence of smoking among men. Tobacco, however, cannot account for the recent trends registered in women.",
author = "Fabio Levi and F. Lucchini and E. Negri and {La Vecchia}, C.",
year = "2004",
month = "7",
doi = "10.1093/annonc/mdh270",
language = "English",
volume = "15",
pages = "1130--1135",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "7",

}

TY - JOUR

T1 - Declining mortality from kidney cancer in Europe

AU - Levi, Fabio

AU - Lucchini, F.

AU - Negri, E.

AU - La Vecchia, C.

PY - 2004/7

Y1 - 2004/7

N2 - Mortality rates from kidney cancer increased throughout Europe up until the late 1980s or early 1990s. Trends in western European countries, the European Union (EU) and selected central and eastern European countries have been updated using official death certification data for kidney cancer abstracted from the World Health Organisation (WHO) database over the period 1980-1999. In EU men, death rates increased from 3.92 per 100 000 (age standardised, world standard) in 1980- 81 to 4.63 in 1994-95, and levelled off at 4.15 thereafter. In women, corresponding values were 1.86 in 1980-81, 2.04 in 1994-95 and 1.80 in 1998-99. Thus, the fall in kidney cancer mortality over the last 5 years was over 10% for both sexes in the EU. The largest falls were in countries with highest mortality in the early 1990s, such as Germany, Denmark and the Netherlands. Kidney cancer rates levelled off, but remained very high, in the Czech Republic, Baltic countries, Hungary, Poland and other central European countries. Thus, in the late 1990s, a greater than three-fold difference in kidney cancer mortality was observed between the highest rates in the Czech Republic, the Baltic Republics and Hungary, and the lowest ones in Romania, Portugal and Greece. Tobacco smoking is the best recognised risk factor for kidney cancer, and the recent trends in men, mainly in western Europe, can be related to a reduced prevalence of smoking among men. Tobacco, however, cannot account for the recent trends registered in women.

AB - Mortality rates from kidney cancer increased throughout Europe up until the late 1980s or early 1990s. Trends in western European countries, the European Union (EU) and selected central and eastern European countries have been updated using official death certification data for kidney cancer abstracted from the World Health Organisation (WHO) database over the period 1980-1999. In EU men, death rates increased from 3.92 per 100 000 (age standardised, world standard) in 1980- 81 to 4.63 in 1994-95, and levelled off at 4.15 thereafter. In women, corresponding values were 1.86 in 1980-81, 2.04 in 1994-95 and 1.80 in 1998-99. Thus, the fall in kidney cancer mortality over the last 5 years was over 10% for both sexes in the EU. The largest falls were in countries with highest mortality in the early 1990s, such as Germany, Denmark and the Netherlands. Kidney cancer rates levelled off, but remained very high, in the Czech Republic, Baltic countries, Hungary, Poland and other central European countries. Thus, in the late 1990s, a greater than three-fold difference in kidney cancer mortality was observed between the highest rates in the Czech Republic, the Baltic Republics and Hungary, and the lowest ones in Romania, Portugal and Greece. Tobacco smoking is the best recognised risk factor for kidney cancer, and the recent trends in men, mainly in western Europe, can be related to a reduced prevalence of smoking among men. Tobacco, however, cannot account for the recent trends registered in women.

UR - http://www.scopus.com/inward/record.url?scp=4143064795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143064795&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdh270

DO - 10.1093/annonc/mdh270

M3 - Article

C2 - 15205209

AN - SCOPUS:4143064795

VL - 15

SP - 1130

EP - 1135

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 7

ER -